Immune cover image

Immune 4: Putting the immunotherapy CAR T before the cancer

Immune

00:00

Which T cell subsets to use?

Hosts discuss pros and cons of using CD8, memory, or naive T cell populations for CAR engineering.

Play episode from 31:30
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app